Dexmedetomidine reduces perioperative opioid consumption and postoperative pain intensity in neurosurgery: A meta-analysis
Journal of Neurosurgical Anesthesiology | Mar 22, 2018
Liu Y, et al. - The efficacy of dexmedetomidine (DEX) for managing pain in neurosurgical patients was assessed. With the use of DEX, a reduction in perioperative and postanesthesia care unit opioid consumption as well as postoperative pain intensity could be achieved.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries